Lag and Loss Blamed on Drug Pricing System, JPMA Set to Get Involved in Corrective Steps: President

JPMA President Hiroaki Ueno Japan’s emerging issue of drug lags and losses is attributed to its pharmaceutical pricing system, and the Japan Pharmaceutical Manufacturers Association (JPMA) is eager to get involved in measures to remedy the problems, the group’s new...read more